Johnson & Johnson
Johnson & Johnson is the world's largest and most diversified healthcare company, organized since the 2023 Kenvue consumer-health spin-off into two segments: Innovative Medicine (pharmaceuticals) and MedTech (medical devices). Reported 2025 sales were ~$94.2B, with Innovative Medicine at $60.4B (~64%) and MedTech at $33.8B (~36%); MedTech spans Surgery (Ethicon), Cardiovascular/Electrophysiology (Biosense Webster), Vision, and Orthopaedics (DePuy Synthes, which J&J announced it will separate into a standalone company). J&J is itself a major surgical-robotics maker, fielding the commercial Velys (orthopedic) and Monarch (bronchoscopy) platforms and developing the Ottava general-surgery robot. For AGD, the relevant surface is J&J's OWN manufacturing: it operates more plants in the US than any other country and announced a $55B+ four-year US investment in advanced manufacturing facilities, R&D, and technology, and is actively hiring factory robotics/automation engineers. HQ in New Brunswick, New Jersey.
Recommended pilots
All use cases — ranked
● validated · ○ researched| Use case | Source | Failure tol. | Tactile | Readiness | Demand |
|---|---|---|---|---|---|
| ★Drug-device combination assembly: inserting fragile prefilled glass syringes into autoinjectors/pens ↗ | medium | high | stretch | promising | |
| Fine assembly of steerable EP/ablation catheters (Biosense Webster) and flexible bronchoscopy devices ↗ | medium | very high | stretch | weak | |
| Precision electro-mechanical assembly of surgical-robotic instruments and modules (OTTAVA) ↗ | medium | very high | aspirational | strong |